ALLEMAN, AR.; BAIN PR. (2000). Diagnosis neoplasia: the cytologic criteria for
malignancy. Vet Med; 95, 3: 204-223
BATEMAN, SC; CATTON, PA; PENNOCK, PW and KRUTH, SA. (1994). 0-7-21 Radiation therapy for treatment of canine oral melanoma. J Vet Intern Med; 8: 267-272.
BOLON, B; CALDERWOOD-MAYS MB and HALL, BJ. (1990). Characteristc of canine melanomas and comparison of histology and DNA ploidy to their biologic behavior. Vet Pathol; 27: 96-102.
DORN, CR and PRIESTER, WA. (1976). Epidemiologic analysis of oral and pharyngeal cancer in dogs, cats, horses and cattle. J Am Vet Med Assoc; 169: 1202- 1206.
GOLDSCHMID, MH; DUNSTAN, RW; STANNARD, A and TSCHARNER V. (1998) Histological classification of epithelial and melanocytic tumors of the skin, Edit forces institute of pathology. -HAHN, KA; BRAVO, L; ADAMS, WH and FRAZIER, DL; . (1994). Naturally occurring tumors in dog as comparative models for cancer therapy research. In Vivo; 8: 133- 143.
HARVEY, HJ. (1981). Prognostic criteria for dogs with oral melanoma. JAVMA; 6: 580-582.
KITCHELL, BE. (1994). Intralesional implants for treatmet of primary oral malignant melanoma in dog. JAVMA 1994; 2: 229-236.
KOENIG, A; BIANCO, SR; FOSMIRE, S; WOJCIESZYNJ and MODIANO, JF. (2002). Expression and significance of p53, Rb, p21/waf-1, p16/Ink-4a, and PTEN tumors suppressors in canine melanoma. Vet Pathol; 39: 458-472. 
LAPRIE, C; ABADIE, J; AMARDEIL, MF et al. (2001) mib-1 immunoreactivity correlates with biologic behaviour in canine cutaneous melanoma. Vet Dermatol; 12: 139
LEVINE, RA and FLEISCHLI, MA. (2000) Inactivation of p53 and retinoblastoma
family pathways in canine osteosarcoma cell lines. Vet Pathol; 37: 54-61.
MACEWEN, EG. (1999). Canine oral melanoma: comparison of surgery versus surgery plus. Cancer Invest; 12: 4249-4258.
MACVEAN, DW. (1978). Frequency of canine and feline tumors in a defined population. Vet Pathol; 6: 715-718.
MAGALHÃES, AM; RAMADINHA, RR; BARROS, CS; PEIXOTO, P;. (2001) Estudo comparativo entre citopatologia e histopatologia no diagnóstico de neoplasias caninas. Pesq. Vet. Bras. 21(1):23-32. 
MARINO, DJ; MATTHIESEN, DT; STEFANACCI, JD and MOROFF, SD. (1995). Evaluation of dogs with digit masses: 117 cases (1981-1991). J Am Vet Med Assoc; 207: 726-728.
MEUTEN, DJ. (2002). Tumors in domestic animals, Iowa state press, fourth edition.
MODIANO, JF; MICHELLE, GR and WOJCIESZYNJ. (1999). The molecular basis of canine melanoma: pathogenesis and trends in diagnosis and therapy. J Vet Intern Med; 13: 163-174.
MOULTON JE. (1990). Tumors in domestic animals, 3rd edition, Berkeley, CA; University of California press: 75.87. 
PATTERSON, H; LATIMER, K. (2001). The variable cytologic appearance of canine melanoma Class (Patterson), and Department of Pathology (Latimer), College of Veterinary Medicine, The University of Georgia Athens, GA 30602- 7388
RAMOS-VARA, JA; BEISSENHERZ, ME; MILLER, MA and JOHNSON, GC. (2000).Retrospective study of 338 canine oral melanomas with clinical, histological and inmunohistochemical review of 129 cases. Vet Pathol; 37: 597-608.
SHOLA, S; SULAIMON; BARBERA, E. and KITCHELL, B. (2001).Canine melanoma; combating a destructive and deadly tumor. Vet Med: 931-942. 
SMITH, SH; GOLDSCHMIDT, MH. and MACMANUS, PM. (2002). A comparative review of melanocytic neoplasm. Vet Pathol; 39: 651-678. 
SULAIMON, S; EHRHART, E. and KITCHELL, B. (1999). Inmunihistochemical detection of canine melanomas with HMB-45. Vet Pathol; 36: 496-501.
THEON, AP; RODRIGUEZ, C. and MADEWELL, BR. (1997). Analysis of prognostic factors and patterns of failure in dogs with malignant oral tumors treated with megavoltage irradiation. J Am Vet Med Assoc; 210: 778-784.